Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04273022 · ClinicalTrials.gov registry record · NA

Effect of Exercise on Biomarkers in SCT

A NA study, sponsored by St. Louis University.

Completed
Registry status
NA
Development phase
12
Enrollment target

NCT04273022 is a NA study that has completed, run by St. Louis University. The registered enrollment target is 12 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04273022, a NA study, has completed, sponsored by St. Louis University.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target

Study Summary

This study measures the effect of exercise on a variety of biomarkers in blood and urine selected to evaluate the physiological pathways of hemolysis, myolysis, thrombosis, inflammation, and renal function in subjects with sickle cell trait. These pathways have been shown to be associated with adverse events in athletes and warfighters with SCT upon protracted, repeated, strenuous exertion. Changes in biomarkers post-exercise compared to pre-exercise (and compared to healthy controls) suggest activation of the associated pathway(s) which may contribute to exercise-related events in athletes and warfighters and subclinical complications in non-athletes.

Interventions

  • OTHER Exercise

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2021-12-27
Est. Completion 2024-12-31
Phase NA

Sponsor

St. Louis University

107 total trials

What the Registry Record Tells You About NCT04273022

The ClinicalTrials.gov registry entry for NCT04273022 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Louis University, which has 107 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Exercise is the first listed.

NCT04273022 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04273022 about?

NCT04273022 is a clinical study titled "Effect of Exercise on Biomarkers in SCT". This study measures the effect of exercise on a variety of biomarkers in blood and urine selected to evaluate the physiological pathways of hemolysis, myolysis, thrombosis, inflammation, and renal function in subjects with sickle cell trait. These pathways have been shown to be associated with adver...

What is the current status of trial NCT04273022?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2021-12-27. Estimated completion is 2024-12-31.

What interventions are being tested in trial NCT04273022?

The interventions under investigation include: Exercise (OTHER).

Who is sponsoring clinical trial NCT04273022?

This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.